News | October 13, 2023
Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
The composition of ORAAL is protected by a granted patent in India until November 2033
The composition of ORAAL is protected by a granted patent in India until November 2033
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Subscribe To Our Newsletter & Stay Updated
